XTNT — Xtant Medical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $123.71m
- $139.96m
- $91.30m
- 30
- 62
- 51
- 45
Annual cashflow statement for Xtant Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.22 | -7.02 | -4.85 | -8.48 | 0.66 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.22 | 7.49 | 3.16 | 4.66 | -7.81 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.55 | -3.27 | 0.793 | -2.81 | -3.63 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.413 | -0.731 | 0.439 | -5.34 | -9.52 |
| Capital Expenditures | -0.879 | -1.54 | -2.12 | -1.76 | -1.46 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.335 | 0.241 | 0.225 | 0.205 | -23.3 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.544 | -1.3 | -1.89 | -1.56 | -24.8 |
| Financing Cash Flow Items | -0.148 | -1.06 | -0.337 | 0 | -0.261 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.603 | -0.861 | 17.5 | 9.02 | 19.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.56 | -2.9 | 16 | 2.12 | -14.6 |